Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

721 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term follow-up of people who have survived cancer during childhood.
Skinner R, Wallace WH, Levitt GA; UK Children's Cancer Study Group Late Effects Group. Skinner R, et al. Lancet Oncol. 2006 Jun;7(6):489-98. doi: 10.1016/S1470-2045(06)70724-0. Lancet Oncol. 2006. PMID: 16750499 Review.
Assessment of chemotherapy-associated nephrotoxicity in children with cancer.
Skinner R, Pearson AD, Coulthard MG, Skillen AW, Hodson AW, Goldfinch ME, Gibb I, Craft AW. Skinner R, et al. Cancer Chemother Pharmacol. 1991;28(2):81-92. doi: 10.1007/BF00689694. Cancer Chemother Pharmacol. 1991. PMID: 2060086 Review.
Strategies to prevent nephrotoxicity of anticancer drugs.
Skinner R. Skinner R. Curr Opin Oncol. 1995 Jul;7(4):310-5. doi: 10.1097/00001622-199507000-00003. Curr Opin Oncol. 1995. PMID: 7578377 Review.
Ifosfamide, mesna, and nephrotoxicity in children.
Skinner R, Sharkey IM, Pearson AD, Craft AW. Skinner R, et al. J Clin Oncol. 1993 Jan;11(1):173-90. doi: 10.1200/JCO.1993.11.1.173. J Clin Oncol. 1993. PMID: 8418231 Review.
Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics.
Boddy AV, English M, Pearson AD, Idle JR, Skinner R. Boddy AV, et al. Among authors: skinner r. Eur J Cancer. 1996 Jun;32A(7):1179-84. doi: 10.1016/0959-8049(96)00019-6. Eur J Cancer. 1996. PMID: 8758250 Clinical Trial.
Risk factors for ifosfamide nephrotoxicity in children.
Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW. Skinner R, et al. Lancet. 1996 Aug 31;348(9027):578-80. doi: 10.1016/s0140-6736(96)03480-0. Lancet. 1996. PMID: 8774570
Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
Ashraf MS, Skinner R, English MW, Craft AW, Pearson AD. Ashraf MS, et al. Among authors: skinner r. Med Pediatr Oncol. 1997 Jan;28(1):62-4. doi: 10.1002/(sici)1096-911x(199701)28:1<62::aid-mpo12>3.0.co;2-c. Med Pediatr Oncol. 1997. PMID: 8950339
How to organise the paediatric MRCP (UK) part II clinical examination.
Skinner R, Wright CM, Craft AW. Skinner R, et al. Arch Dis Child. 1997 Jun;76(6):545-8. doi: 10.1136/adc.76.6.545. Arch Dis Child. 1997. PMID: 9245859 Free PMC article. No abstract available.
Cisplatin dose rate as a risk factor for nephrotoxicity in children.
Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW. Skinner R, et al. Br J Cancer. 1998 May;77(10):1677-82. doi: 10.1038/bjc.1998.276. Br J Cancer. 1998. PMID: 9635848 Free PMC article.
Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.
Skinner R, Cotterill SJ, Stevens MC. Skinner R, et al. Br J Cancer. 2000 May;82(10):1636-45. doi: 10.1054/bjoc.2000.1214. Br J Cancer. 2000. PMID: 10817497 Free PMC article.
721 results
Jump to page
Feedback